CLDN18.2 Targeting Nanobody Probe for PET Imaging in Solid Tumors

Summary

The objective of the study is to construct a noninvasive approach 68Ga-ACN376 PET/CT to detect the CLDN18.2 expression of tumor lesions in patients with Solid tumors and to identify patients benefiting from CLDN18.2 targeting treatment.

Timeline

Start

2022-06-23

Primary completion

2026-12

Completion

2027-12

Drugs

Indications